Pfizer 1Q Revenues: $12.7 billion (-3%) 1Q Earnings: $4.1 billion (earnings were $301 million 1Q2005) Comments: Worldwide sales of Lipitor were $3.1 billion in the quarter, up 3%. Sales of Celebrex were $491 million, up 19%. Lyrica sales were $192 million in the quarter as compared to $20 million in 1Q2005. U.S. approvals in the quarter include: Sutent, Exubera, and Eraxis. The low earnings in 1Q2005 were due to charges related to the withdrawal of Bextra and the tax charge from rep...